This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Ridgefield, Conn., and Ingelheim, Germany, Feb. 19, 2025 -- Boehringer Ingelheim...
Sydney, Australia 19 February 2025 Clarity Pharmaceuticals (ASX: CU6) (“Clarity”...
The annual International Stroke Conference of the American Heart Association/Ame...
Clinical trial organization Flourish Research has made a deal with Diablo Clinic...
As always, if you know of layoffs occurring at a biotech, please reach out to th...
CRISPR-based Spotlight Therapeutics has shut down, former CEO Mary Haak-Frendsch...
Cabaletta’s new data slice for its investigational CD19-CAR T cell therapy shows...
WEDNESDAY, Feb. 19, 2025 -- Formulation characteristics can explain much of the...
AdvaMed, the medical device lobby, pushed back Wednesday on the Trump administra...
Bristol Myers Squibb has bolstered its case for Opdivo to be used as a preoperat...
To support the launch of Tryngolza, which is approved to treat adults with famil...
While the FDA’s diversity guidance for clinical trials has been temporarily rest...
In response to Trump science policies, universities are accepting fewer graduate...
It’s only possible to lower taxes without touching major government entitlement ...
Charles River Laboratories is continuing to downsize certain parts of its organi...
After privately vying for a change to Dynavax’s corporate strategy for months, l...
To support the launch of Tryngolza, which is approved to treat adults with famil...
While the FDA’s diversity guidance for clinical trials has been temporarily rest...
Siemens Healthineers aims to speed up deliveries to customers with new “mega dep...
After privately vying for a change to Dynavax’s corporate strategy for months, l...
Dr. Oz's assets range from a tree trimming company to a cattle farm to UnitedHea...
As argenx continues to rise to profitability based on the strength of its indica...
Salt Lake City-based accelerator Altitude Lab is hoping it can entice biotechs c...
The agency responded to Harmony's bid for an idiopathic hypersomnia nod for exce...